FDA Inspection
Novo Nordisk US Bio Production Inc.Novo Nordisk US Bio Production Inc. – FDA Inspection, Dec 9, 2025
Record Details
This FDA Inspection record concerns Novo Nordisk US Bio Production Inc., with an inspection on December 9, 2025, issued by the New England District Office, covering human drugs.
View Company Profile
ID · b0077115-b9ef-46ae-81a7-75debc87bcbd
Inspection Facts
- Inspection number
- 1292060
- FDA center
- Human Drugs
Other FDA inspections of Novo Nordisk US Bio Production Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 25, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2018 | Not classified | New England District Office |
Other documents for Novo Nordisk US Bio Production Inc.
- FDA Inspection 1255809 - 2025-03-05
- FDA Inspection 1214482 - 2023-07-25
- FDA Inspection 1064794 - 2018-08-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.